Finance

Beta
Lists
603520:SHA
Zhejiang Starry Pharmaceutical Co Ltd
CN¥9.25
-1.07%
(-0.10) 1D
Jun 10, 3:00:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603520...
Open
CN¥9.23
High
CN¥9.39
Low
CN¥9.08
Mkt. cap
4.10B
Avg. vol.
37.96M
Volume
13.04M
Dividend
3.24%
Quarterly dividend
CN¥0.08
Ex-dividend date
Jun 4, 2026
P/E ratio
240.89
52-wk high
CN¥14.37
52-wk low
CN¥9.08
EPS
CN¥0.04
Shares outstanding
120.00M
No. of employees
2K
Open
CN¥9.23
High
CN¥9.39
Low
CN¥9.08
Mkt. cap
4.10B
Avg. vol.
37.96M
Volume
13.04M
Dividend
3.24%
Quarterly dividend
CN¥0.08
Ex-dividend date
Jun 4, 2026
P/E ratio
240.89
52-wk high
CN¥14.37
52-wk low
CN¥9.08
EPS
CN¥0.04
Shares outstanding
120.00M
No. of employees
2K
News stories
From sources across the web
About Zhejiang Starry Pharmaceutical Co Ltd
CEO-
Employees1.9K
FoundedSep 15, 1997
Headquarters-
SectorPharmaceutical industry
Websitestarrypharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
711.86M
447.26M
600.76M
711.27M
Cost of goods sold
563.04M
315.76M
530.64M
552.98M
Cost of revenue
563.04M
315.76M
530.64M
552.98M
Research and development expenses
42.91M
28.97M
37.20M
28.28M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
71.01M
68.25M
55.26M
65.75M
Operating expense
122.02M
85.31M
100.75M
90.72M
Total operating expenses
685.05M
401.07M
631.39M
643.71M
Operating income
26.81M
46.19M
-30.63M
67.56M
Other non operating income
-6.92M
9.79M
-17.11M
-33.85M
EBT including unusual items
22.83M
-1.25M
-30.84M
27.63M
EBT excluding unusual items
18.28M
22.63M
-46.43M
33.71M
Income tax expense
7.63M
-944.92K
-11.95M
6.82M
Effective tax rate
33.43%
75.71%
38.76%
24.67%
Other operating expenses
3.91M
-8.07M
8.64M
-3.30M
Net income
14.79M
-310.63K
-18.60M
20.95M
Net profit margin
2.08%
-0.07%
-3.10%
2.95%
Earnings per share
-
-
-
-
Interest and investment income
652.70K
374.11K
360.05K
-
Interest expense
-18.62M
-17.36M
-19.19M
-
Net interest expenses
-17.96M
-16.99M
-18.83M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
82.35M
100.91M
28.95M
127.14M
Gain or loss from assets sale
-262.77K
262.77K
-447.30K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer